European Union research programme receives 7% boost:
This article was originally published in Clinica
Funding of the European Union's Fourth Framework Research programme, which includes Ecu 888 million ($668 million) for biotechnology, biomedicine and health, is to receive a 7% top- up to Ecu 13,160 million due to the recent expansion of the Union to include Austria, Finland and Sweden. The increase was agreed at the European Parliament's July session in Strasbourg where another more contentious issue was debated concerning the level of additional funding to be allocated when the four-year programme is subjected to mid-term review in 1997.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.